Educational Sessions: "Management of special subtypes of TNBC"

Educational Sessions: "Management of special subtypes of TNBC"Подробнее

Educational Sessions: 'Management of special subtypes of TNBC'

Educational Sessions: "Genomic and transcriptomic landscape of TNBC"Подробнее

Educational Sessions: 'Genomic and transcriptomic landscape of TNBC'

Educational Sessions: "Optimizing the management of early stage TNBC"Подробнее

Educational Sessions: 'Optimizing the management of early stage TNBC'

Educational Sessions: "IO beyond TNBC"Подробнее

Educational Sessions: 'IO beyond TNBC'

Education Session Inflammatory BC: Clinical Challenges, Evolving Concepts and Novel treatmentПодробнее

Education Session Inflammatory BC: Clinical Challenges, Evolving Concepts and Novel treatment

Triple negative breast cancerПодробнее

Triple negative breast cancer

The importance of a biomarker-directed approach in triple-negative breast cancerПодробнее

The importance of a biomarker-directed approach in triple-negative breast cancer

Optimal chemotherapy combinations in TNBC gBRCA subtypesПодробнее

Optimal chemotherapy combinations in TNBC gBRCA subtypes

Targeting Advanced Triple-Negative Breast Cancer | Dana-Farber Cancer InstituteПодробнее

Targeting Advanced Triple-Negative Breast Cancer | Dana-Farber Cancer Institute

Dr. Bora Lim | Challenging Types of Breast Cancer | SABCS 2022 | Education SessionПодробнее

Dr. Bora Lim | Challenging Types of Breast Cancer | SABCS 2022 | Education Session

Histologic Subtyping in TNBCПодробнее

Histologic Subtyping in TNBC

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy ConsiderationsПодробнее

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy Considerations

Educational Sessions: "Special indications where local therapy should be considered"Подробнее

Educational Sessions: 'Special indications where local therapy should be considered'

Breast Cancer Breakout: Rapid research developments and new treatment combinationsПодробнее

Breast Cancer Breakout: Rapid research developments and new treatment combinations

Breast Cancer Trials Q&A: Triple Negative Breast CancerПодробнее

Breast Cancer Trials Q&A: Triple Negative Breast Cancer

#CABC#Triple Negative Breast Cancer Is Most Chemo-sensitive of All Subtypes of CancerПодробнее

#CABC#Triple Negative Breast Cancer Is Most Chemo-sensitive of All Subtypes of Cancer

Testing, Treating, and Targeting Triple Negative Breast Cancer | 2023 West Oncology ConferenceПодробнее

Testing, Treating, and Targeting Triple Negative Breast Cancer | 2023 West Oncology Conference

New Frontiers in Triple Negative Breast CancerПодробнее

New Frontiers in Triple Negative Breast Cancer

Let’s Talk About It: Triple-Negative Breast Cancer - Cutting-Edge Research on TNBCПодробнее

Let’s Talk About It: Triple-Negative Breast Cancer - Cutting-Edge Research on TNBC

Новости